文献速递系统性红斑狼疮类风湿关节炎

RISE登记系统中SLE与RA育龄女性避孕记录频率研究

Frequency of Contraception Documentation in Women With Systemic Lupus Erythematosus and Rheumatoid Arthritis Within the Rheumatology Informatics System for Effectiveness Registry.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-10-31

基于美国RISE电子健康记录登记系统,纳入2018年18-45岁、至少有2次就诊且诊断为SLE或RA的女性,SLE 9826例、RA 19009例,仅9.1%有避孕记录。SLE女性避孕记录率显著低于RA(校正OR 0.84,95%CI 0.76-0.92),西班牙裔及黑人和亚裔女性均低于白人女性。

要点

  • RISE登记系统中育龄SLE和RA女性仅9.1%有避孕记录。
  • SLE女性避孕记录率显著低于RA女性。
  • 西班牙裔及黑人和亚裔女性避孕记录率低于白人女性。

核心结论

  • RISE登记系统中避孕记录存在很大缺口,少数族裔女性尤为突出。
  • 数据可能低估避孕使用,但提示多数风湿科医生未系统收集和记录该信息。

研究设计与样本

  • 基于美国RISE电子健康记录登记系统的研究。
  • 纳入2018年18-45岁、至少有2次就诊且任何时候有SLE或RA诊断代码的女性。
  • 从结构化数据字段收集避孕记录,采用单因素和多因素分析比较频率。

主要发现

  • 2018年育龄女性中SLE 9826例、RA 19009例,其中9.1%有避孕记录。
  • SLE女性避孕记录率显著低于RA(校正OR 0.84,95%CI 0.76-0.92)。
  • 西班牙裔以及黑人和亚裔女性均比白人女性更少有可能有避孕记录。
  • 致畸药物处方与RA女性较高的避孕记录率相关(校正OR 1.31,95%CI 1.16-1.47),与SLE女性无关(校正OR 1.08,95%CI 0.91-1.28)。

关键数值与推荐

  • SLE女性校正OR 0.84(95%CI 0.76-0.92),参照RA女性。
  • RA女性致畸药物处方校正OR 1.31(95%CI 1.16-1.47)。
  • SLE女性致畸药物处方校正OR 1.08(95%CI 0.91-1.28)。

临床怎么用

  • 风湿科医生应建立系统化流程,在电子健康记录中收集和记录育龄女性避孕信息。
  • 对SLE女性及少数族裔女性尤需关注避孕记录缺口。

局限性

  • 数据可能低估避孕使用。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We sought to understand the frequency of contraception documentation for women with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in a large US electronic health record (EHR)-based registry and to identify disparities by teratogen prescription and patient race and ethnicity. METHODS: Contraception documentation from structured data fields within the Rheumatology Informatics System for Effectiveness (RISE) registry was collected for women of childbearing age (18-45 years) in 2018 who had at least 2 visits with International Classification of Diseases, Ninth Revision or Tenth Revision, diagnosis codes for SLE or RA (at any time). Univariate and multivariate analyses compared the frequency of contraception documentation based on patient characteristics including diagnosis, age, race, and teratogenicity of prescribed antirheumatic medications. RESULTS: In 2018, there were 9,826 women of childbearing age with SLE and 19,009 with RA, of whom 9.1% had any contraception documented. Rates of contraceptive documentation were significantly lower for women with SLE (adjusted odds ratio [OR] 0.84 [95% confidence interval (95% CI) 0.76-0.92]). Women of Hispanic ethnicity and Black and Asian race were all less likely than White women to have contraception documentation. Teratogen prescription was associated with higher rates of contraception documentation for women with RA but not SLE (RA adjusted OR 1.31 [95% CI 1.16-1.47]; SLE adjusted OR 1.08 [95% CI 0.91-1.28]). CONCLUSION: There are large gaps in contraception documentation within the RISE registry that are particularly stark among women of color. Although these data likely underestimate contraception use, they highlight that most rheumatologists do not have a systematic approach to collecting and recording this information in the EHR.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Clowse MEB, Li J, Talabi MB, et al. Frequency of Contraception Documentation in Women With Systemic Lupus Erythematosus and Rheumatoid Arthritis Within the Rheumatology Informatics System for Effectiveness Registry. Arthritis Care Res (Hoboken). 2022. PMID: 34623033. doi:10.1002/acr.24803

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。